
浏览全部资源
扫码关注微信
400038 重庆,陆军军医大学(第三军医大学)第一附属医院药剂科
[夏培元,E-mail:peiyuan_xia2013@163.comXIA Peiyuan, E-mail: peiyuan_xia2013@163.com
收稿:2017-08-28,
修回:2017-12-12,
纸质出版:2018-03-15
移动端阅览
张镭, 孙凤军, 冯伟, 等. 临床尿路感染分离大肠埃希菌的耐药性及毒力分析[J]. 第三军医大学学报, 2018,40(5):420-425.
Lei ZHANG, Fengjun SUN, Wei FENG, et al. Resistance and virulence of
张镭, 孙凤军, 冯伟, 等. 临床尿路感染分离大肠埃希菌的耐药性及毒力分析[J]. 第三军医大学学报, 2018,40(5):420-425. DOI: 10.16016/j.1000-5404.201708186.
Lei ZHANG, Fengjun SUN, Wei FENG, et al. Resistance and virulence of
目的
2
观察急性单纯性和反复性尿路感染大肠埃希菌耐药性及毒力因子的差异,探讨临床尿路感染菌株的致病力。
方法
2
收集本院2014-2015年住院患者临床送检标本,采用平板倍比稀释法检测标本细菌的最低抑菌浓度(minimal inhibitory concentration,MIC),以细菌平板计数法检测大肠埃希菌的黏附能力,通过细菌的泳动力实验检测大肠埃希菌的运动能力,并用血凝实验检测大肠埃希菌的溶血能力,乳酸脱氢酶实验检测细菌对膀胱癌5637细胞的毒性。
结果
2
共分离出26株大肠埃希菌,其中15株为反复性尿路感染分离菌株(反复性组),11株为急性单纯性尿路感染分离菌株(急性单纯性组),毒力结果如下:反复性组黏附能力[(4.95×10
7
±1.21×10
6
)CFU/mL
]
显著强于急性单纯性组[(2.57×10
7
±1.63×10
6
)CFU/mL,
P
<0.001
]
;反复性组溶血能力(7.30±0.58)也强于急性单纯性组;反复性组菌株对5637细胞的毒性[(76.66±3.65)%
]
显著高于急性单纯性组[(64.14±8.85)%,
P
=0.019
]
;但两组耐药性、运动能力差异无统计学意义(
P
>
0.05)。
结论
2
反复性尿路感染菌株比急性单纯性尿路感染菌株致病力更强。
Objective
2
To investigate the differences in drug resistance and virulence factor of
Escherichia coli
(
E.coli
) strains isolated from the patients with recurrent and acute simple urinary tract infection.
Methods
2
The
clinical samples of the hospitalized patients in our hospital from 2014 to 2015 were collected. Then the minimal inhibitory concentration of the strains was tested by the agar double dilution. The adhesion of the
E. coli
strains was tested with flat colony counting. The motility of
E. coli
was analyzed by the diameter of the zone on the semisolid medium. Type 1 fimbriation was determined by a rabbit erythrocyte hemagglutination for the hemolysis of
E. coli
. The virulence of
E. coli
to the 5637 cells was tested by lactate dehydrogenase test.
Results
2
There were 26 strains of
E. coli
isolated from clinical samples
including 15 from the patients of recurrent and 11 from acute simple urinary tract infection. For the toxicity of the strains
the adhesion ability was 4.95×10
7
±1.21×10
6
CFU/mL for the recurrent isolates and 2.57×10
7
±1.63×10
6
CFU/mL in the acute isolates (
P
<
0.001). The recurrent isolates had stronger hemagglutination (7.3±0.58
vs
6.03±0.73
P
<
0.001)
and stronger toxicity to 5637 cells [(76.66±3.65)%
vs
(64.14±8.85)%
P
=0.019
]
than the acute isolates. Whereas
there were no significant differences in the resistance and motility of the 2 kinds of isolates (
P
>
0.05).
Conclusion
2
The
E. coli
strains isolated from recurrent urinary tract infections have higher virulent than those from acute simple urinary tract infections.
NICOLLE L E. The prevention of hospital-acquired urinary tract infection[J]. Clin Infect Dis, 2008, 46(2): 251-253. DOI:10.1086/524663.
CHEN L F, CHIU C T, Lo J Y, et al . Clinical characteristics and antimicrobial susceptibility pattern of hospitalized patients with community acquired urinary tract infections at a regional hospital in Taiwan[J ] . Healthc Infect, 2013, 19(1): 20-25. DOI:10.1071/HI13033.
BIEN J, SOKOLOVA O, BOZKO P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage[J ] . Int J Nephrol, 2012, 2012: 681473. DOI:10.1155/2012/681473.
NAGAMATSU K, HANNAN T J, GUEST R L, et al . Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection[J ] . Proc Natl Acad Sci U S A, 2015, 112(8): E871-E880. DOI:10.1073/pnas.1500374112..
HANNAN T J, MYSOREKAR I U, Hung C S, et al . Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection[J ] . PLoS Pathog, 2010, 6(8): e1001042. DOI:10.1371/journal.ppat.1001042..
HULTGREN S J, SCHWAN W R, SCHAEFFER A J, et al . Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli [J ] . Infect Immun, 1986, 54(3): 613-620..
GONEAU L W, HANNAN T J, MACPHEE R A, et al . Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity[J ] . Mbio, 2015, 6(2).pii: e00356-15. DOI:10.1128/mbio.00356-15.
ZHANG X, LI Y, LI B, et al . Three supplementary methods for analyzing cytotoxicity of Escherichia coli O157:H7[J ] . J Microbiol Methods, 2016, 120: 34-40. DOI:10.1016/j.mimet.2015.11.011..
BERGSTEN G, WULLT B, SVANBORG C. Escherichia coli , fimbriae, bacterial persistence and host response induction in the human urinary tract[J ] . Int J Med Microbiol, 2005, 295(6/7): 487-502. DOI:10.1016/j.ijmm.2005.07.008.
SUBASHCHANDRABOSE S, HAZEN T H, BRUMBAUGH A R, et al . Host-specific induction of Escherichia coli fitness genes during human urinary tract infection[J ] . Proc Natl Acad Sci USA, 2014, 111(51): 18327-18332. DOI:10.1073/pnas.1415959112..
BLANGO M G, MULVEY M A. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics[J ] . Antimicrob Agents Chemother, 2010, 54(5): 1855-1863. DOI:10.1128/aac.00014-10.
EJRNAES K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli [J ] . Dan Med Bull, 2011, 58(4): B4187.
BRYCE A, HAY A D, LANE I F, et al . Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis[J ] . BMJ, 2016, 352: i939. DOI:10.1136/bmj.i939..
ABDUZAIMOVIC A, ALJICEVIC M, REBIC V, et al . Antibiotic resistance in urinary isolates of Escherichia coli [J ] . Mater Sociomed, 2016, 28(6): 416-419. DOI:10.5455/msm.2016.28.416-419..
OLSON R P, HAITH K. Antibiotic resistance in urinary tract infections in college students[J]. J Am Coll Health, 2012, 60(6): 471-474. DOI:10.1080/07448481.2012.681410.
SALEHZADEH A, ZAMANI H. Characterization of (Uropathogenic) E. coli isolated from urinary tract infections: phylogenetic typing and distribution of virulence-associated traits[J ] . Br J Biomed Sci, 2017, 75(1): 1-3. DOI:10.1080/09674845.2017.1336834.
QIN X, HU F, WU S, et al . Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains[J ] . PLoS ONE, 2013, 8(4): e61169. DOI:10.1371/j ournal.pone.0061169..
FLOYD K A, MOORE J L, EBERLY A R, et al . Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili[J ] . PLoS Pathog, 2015, 11(3): e1004697. DOI:10.1371/journal.ppat.1004697..
ROSEN D A, PINKNER J S, WALKER J N, et al . Molecular variations in klebsiella pneumoniae and Escherichia coli fimh affect function and pathogenesis in the urinary tract[J ] . Infect Immun, 2008, 76(7): 3346-3356. DOI:10.1128/iai.00340-08..
WRIGHT K J, SEED P C, HULTGREN S J. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili[J ] . Cell Microbiol, 2007, 9(9): 2230-2241. DOI:10.1111/j.1462-5822.2007.00952.x.
BISOGNANO C, VAUDAUX P, ROHNER P, et al . Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant staphylococcus aureus by subinhibitory levels of ciprofloxacin[J ] . Antimicrob Agents Chemother, 2000, 44(6): 1428-1437. DOI:10.1128/aac.44.6.1428-1437.2000.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621